Dyne Therapeutics (DYN.US) was covered for the first time by Damo and was given an increase in holdings rating, with a target price of $40.00.
Dyne Therapeutics(DYN.US)获大摩首次覆盖，给予增持评级, 目标价40.00美元。
Dyne Therapeutics (DYN.US) was covered for the first time by Damo and was given an increase in holdings rating, with a target price of $40.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.